Stockscreener 앱 받기
113.59
1.28%
1.331
시간 외 거래:
113.62
0.029
+0.03%
전일 마감가:
$112.26
열려 있는:
$111.395
하루 거래량:
3.26M
Relative Volume:
0.51
시가총액:
$140.96B
수익:
$28.80B
순이익/손실:
$6.31B
주가수익비율:
22.63
EPS:
5.02
순현금흐름:
$9.37B
1주 성능:
-3.53%
1개월 성능:
-3.64%
6개월 성능:
+3.15%
1년 성능:
+35.53%
1일 변동 폭
$111.26
$113.75
1주일 범위
$110.15
$117.63
52주 변동 폭
$81.83
$121.83
길리어드 사이언스 Stock (GILD) Company Profile
명칭
Gilead Sciences Inc
전화
(650) 574-3000
주소
333 LAKESIDE DR, FOSTER CITY, CA
GILD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GILD
Gilead Sciences Inc
|
113.61 | 139.29B | 28.80B | 6.31B | 9.37B | 5.02 |
|
LLY
Lilly Eli Co
|
762.74 | 681.42B | 53.26B | 13.80B | -50.20M | 15.30 |
|
JNJ
Johnson Johnson
|
174.15 | 426.76B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
222.00 | 390.07B | 58.33B | 3.73B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
122.34 | 237.08B | 53.40B | 13.68B | 16.89B | 6.9231 |
|
NVO
Novo Nordisk Adr
|
61.86 | 258.61B | 45.44B | 16.18B | 9.21B | 3.634 |
길리어드 사이언스 Stock (GILD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-19 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2025-08-08 | 업그레이드 | Truist | Hold → Buy |
| 2025-07-25 | 업그레이드 | Needham | Hold → Buy |
| 2025-04-22 | 재개 | Cantor Fitzgerald | Overweight |
| 2025-03-04 | 재확인 | Oppenheimer | Outperform |
| 2025-02-18 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-02-13 | 업그레이드 | DZ Bank | Hold → Buy |
| 2025-01-10 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | 재개 | BofA Securities | Buy |
| 2024-11-15 | 개시 | Wolfe Research | Outperform |
| 2024-11-14 | 개시 | Citigroup | Buy |
| 2024-11-08 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2024-10-21 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-10-17 | 개시 | Bernstein | Outperform |
| 2024-10-07 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-07-08 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2024-05-01 | 재확인 | Maxim Group | Buy |
| 2024-04-24 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2024-02-22 | 다운그레이드 | Truist | Buy → Hold |
| 2023-11-09 | 개시 | Deutsche Bank | Hold |
| 2023-09-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-09-06 | 개시 | HSBC Securities | Reduce |
| 2023-07-24 | 재확인 | Barclays | Equal Weight |
| 2023-05-16 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2023-04-28 | 재개 | Piper Sandler | Overweight |
| 2023-01-03 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-12-13 | 재개 | BofA Securities | Neutral |
| 2022-12-09 | 다운그레이드 | DZ Bank | Buy → Hold |
| 2022-10-31 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2022-10-28 | 재확인 | BMO Capital Markets | Market Perform |
| 2022-10-28 | 재확인 | Cowen | Outperform |
| 2022-10-28 | 재확인 | JP Morgan | Overweight |
| 2022-10-28 | 재확인 | Jefferies | Buy |
| 2022-10-28 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-10-28 | 재확인 | RBC Capital Mkts | Outperform |
| 2022-10-28 | 업그레이드 | Truist | Hold → Buy |
| 2022-10-28 | 재확인 | Wells Fargo | Equal Weight |
| 2022-10-04 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-07-13 | 개시 | Cantor Fitzgerald | Neutral |
| 2022-05-23 | 개시 | SVB Leerink | Mkt Perform |
| 2022-02-28 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2022-02-02 | 재확인 | BMO Capital Markets | Outperform |
| 2022-02-02 | 재확인 | BofA Securities | Neutral |
| 2022-02-02 | 재확인 | RBC Capital Mkts | Outperform |
| 2022-02-02 | 재확인 | Truist | Hold |
| 2022-02-02 | 재확인 | Wells Fargo | Equal Weight |
| 2022-01-28 | 업그레이드 | Argus | Hold → Buy |
| 2022-01-06 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-09 | 재개 | Wells Fargo | Equal Weight |
| 2021-12-06 | 개시 | Goldman | Neutral |
| 2021-11-19 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2021-11-19 | 재개 | Piper Sandler | Neutral |
| 2021-10-20 | 재개 | Cowen | Outperform |
| 2021-07-30 | 재확인 | BMO Capital Markets | Market Perform |
| 2021-07-30 | 재확인 | RBC Capital Mkts | Outperform |
| 2021-04-01 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2021-03-30 | 업그레이드 | Redburn | Neutral → Buy |
| 2021-01-19 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-01-04 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-11-03 | 재개 | Morgan Stanley | Equal-Weight |
| 2020-10-28 | 개시 | UBS | Neutral |
| 2020-09-30 | 재개 | Jefferies | Buy |
| 2020-09-15 | 업그레이드 | Maxim Group | Hold → Buy |
| 2020-07-31 | 재확인 | Credit Suisse | Neutral |
| 2020-07-31 | 재확인 | Morgan Stanley | Equal-Weight |
| 2020-07-31 | 재확인 | Piper Sandler | Overweight |
| 2020-07-31 | 재확인 | RBC Capital Mkts | Outperform |
| 2020-07-31 | 재확인 | SunTrust | Hold |
| 2020-07-31 | 재확인 | Wells Fargo | Equal Weight |
| 2020-07-20 | 업그레이드 | Credit Suisse | Underperform → Neutral |
| 2020-06-03 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2020-05-26 | 업그레이드 | SunTrust | Sell → Hold |
| 2020-05-01 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-05-01 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-05-01 | 다운그레이드 | SunTrust | Hold → Sell |
| 2020-04-27 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-04-20 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2020-04-20 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | 다운그레이드 | CFRA | Hold → Sell |
모두보기
길리어드 사이언스 주식(GILD)의 최신 뉴스
May 2026 Options Now Available For Gilead Sciences (GILD) - Nasdaq
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know - ca.finance.yahoo.com
Gilead price tries to recoup some lossesForecast today18-09-2025 - Economies.com
Gilead Sciences’ SWOT analysis: biotech giant faces HIV funding headwinds - Investing.com
Confluence Investment Management LLC Decreases Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Procyon Advisors LLC Purchases 3,536 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Financiere des Professionnels Fonds d investissement inc. Purchases 31,948 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Balefire LLC Invests $484,000 in Gilead Sciences, Inc. $GILD - MarketBeat
Everpar Advisors LLC Buys Shares of 3,012 Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Stake Boosted by Wesbanco Bank Inc. - MarketBeat
Stocks With Rising Relative Strength: Gilead Sciences - Investor's Business Daily
Fangzhou Named ‘Outstanding Growth Story in Hong Kong Stocks’ at China Capital Market Development Forum 2025 - GlobeNewswire Inc.
Fangzhou Wins Gilead ‘Award of Excellence’ for AI-Driven Chronic Disease Management - The Manila Times
Gilead Sciences (GILD) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
Gilead Sciences (NASDAQ:GILD) CFO Andrew Dickinson Sells 2,500 Shares - MarketBeat
Johanna Mercier Sells 3,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock - MarketBeat
VIX Spike: Is GPRO stock risky to hold nowStop Loss & AI Based Buy/Sell Signal Reports - خودرو بانک
Lingohr Asset Management GmbH Buys New Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $145.00 at JPMorgan Chase & Co. - MarketBeat
Gilead Sciences, Inc. $GILD Stock Position Lowered by First Bank & Trust - MarketBeat
Gilead Sciences, Inc. $GILD Position Raised by Czech National Bank - MarketBeat
Range Financial Group LLC Sells 2,369 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. (NASDAQ:GILD) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Gilead Sciences, Inc. $GILD Shares Sold by Advisors Capital Management LLC - MarketBeat
Gilead Sciences, Inc. $GILD Shares Sold by Geneos Wealth Management Inc. - MarketBeat
Strs Ohio Invests $57.39 Million in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences CFO sells $283,925 in stock - Investing.com
Redburn Atlantic Maintains a Buy on Gilead Sciences (GILD), Sets a $143 PT - MSN
Good Steward Wealth Advisors LLC Sells 2,926 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
JPMorgan Adjusts Price Target on Gilead Sciences to $145 From $135, Maintains Overweight Rating - MarketScreener
Gilead Sciences, Inc. $GILD Shares Sold by Intech Investment Management LLC - MarketBeat
Plato Investment Management Ltd Sells 15,097 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
IFM Investors Pty Ltd Grows Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Caxton Associates LLP Invests $562,000 in Gilead Sciences, Inc. $GILD - MarketBeat
Published on: 2025-09-16 02:45:49 - خودرو بانک
Stop Loss: Will Gilead Sciences Inc stock recover after earningsWeekly Gains Report & Fast Gaining Stock Strategy Reports - خودرو بانک
Gilead Sciences, Inc. $GILD Shares Sold by Pensionfund Sabic - MarketBeat
Gilead Sciences, Inc. $GILD Shares Bought by Focus Partners Wealth - MarketBeat
Ilmarinen Mutual Pension Insurance Co Acquires 21,000 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Holdings Raised by Fred Alger Management LLC - MarketBeat
Gilead Sciences, Inc. $GILD Shares Bought by Glenview Trust co - MarketBeat
Ascent Group LLC Buys 11,200 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Meiji Yasuda Life Insurance Co Buys 2,945 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Woodline Partners LP Purchases 15,823 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
AG2R LA Mondiale Gestion D Actifs Buys Shares of 46,328 Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Purchased by Voya Investment Management LLC - MarketBeat
Gilead Sciences, Inc. $GILD Shares Bought by Swedbank AB - MarketBeat
Kestra Investment Management LLC Sells 2,391 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Continental Advisors LLC Sells 11,500 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Voleon Capital Management LP Sells 34,020 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
CTC Alternative Strategies Ltd. Invests $784,000 in Gilead Sciences, Inc. $GILD - MarketBeat
길리어드 사이언스 (GILD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
길리어드 사이언스 주식 (GILD) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Dickinson Andrew D | Chief Financial Officer |
Sep 15 '25 |
Sale |
113.57 |
2,500 |
283,925 |
159,555 |
0.42%
자본화:
|
볼륨(24시간):